Portugal Secures First Proton Therapy Center with €70M–€90M IBA Deal
Event summary
- IBA SA secures €70M–€90M contract for two Proteus®ONE proton therapy systems in Portugal.
- Systems to be installed at IPO-Porto, operational by 2029 as the National Proton Therapy Center.
- Deal follows public tender launched after agreement between FAO, Portuguese ministries, and IPO-Porto.
- IBA to provide operation and maintenance services under the contract.
The big picture
This deal solidifies IBA’s leadership in compact proton therapy solutions, addressing a critical gap in Portuguese cancer treatment infrastructure. The partnership between private philanthropy (FAO) and government underscores the strategic importance of advanced oncology care, potentially setting a precedent for similar collaborations across Europe.
What we're watching
- Market Expansion
- Whether IBA can leverage this deal to secure similar contracts in other underserved European markets.
- Technological Integration
- The pace at which Proteus®ONE systems will incorporate future advancements and maintain competitive edge.
- Operational Efficiency
- How dual-system configuration impacts patient throughput and clinical availability in Portugal's first proton therapy center.
Related topics